DASATINIB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 25 adverse event reports in the FDA FAERS database where DASATINIB was used for Prostate cancer.
Most Reported Side Effects for DASATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pleural effusion | 2,424 | 8.1% | 96 | 840 |
| Fatigue | 2,173 | 7.2% | 18 | 286 |
| Death | 1,741 | 5.8% | 1,735 | 110 |
| Nausea | 1,740 | 5.8% | 34 | 251 |
| Diarrhoea | 1,728 | 5.8% | 34 | 299 |
| Headache | 1,625 | 5.4% | 23 | 170 |
| Adverse event | 1,382 | 4.6% | 13 | 261 |
| Rash | 1,300 | 4.3% | 25 | 150 |
| Drug ineffective | 1,271 | 4.2% | 72 | 173 |
| Hospitalisation | 1,181 | 3.9% | 21 | 1,150 |
| Dyspnoea | 1,180 | 3.9% | 35 | 363 |
| Off label use | 1,045 | 3.5% | 132 | 226 |
| Pulmonary oedema | 873 | 2.9% | 24 | 335 |
| Vomiting | 714 | 2.4% | 33 | 196 |
| Drug intolerance | 684 | 2.3% | 10 | 70 |
Other Indications for DASATINIB
Chronic myeloid leukaemia (15,612)
Product used for unknown indication (6,986)
Acute lymphocytic leukaemia (2,255)
Leukaemia (654)
Myeloid leukaemia (411)
Acute myeloid leukaemia (315)
Philadelphia positive acute lymphocytic leukaemia (237)
Philadelphia chromosome positive (191)
Neoplasm malignant (168)
Chronic lymphocytic leukaemia (156)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)